11558 Federal Register / Vol. 86, No. 36 / Thursday, February 25, 2021 / Notices 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on July 20, 2020, Chattem 

Chemicals 3801 Saint Elmo Avenue, 

Chattanooga, Tennessee 37409, applied 

to be registered as a bulk manufacturer 

of the following basic class(es) of 

controlled substance(s): 

Controlled substance Drug 

code Schedule 

Gamma Hydroxybutyric Acid .... 2010 I 

Marihuana ................................. 7360 I 

Tetrahydrocannabinols ............. 7370 I 

4-Methoxyamphetamine ........... 7411 I 

Dihydromorphine ....................... 9145 I 

Norlevorphanol .......................... 9634 I 

Amphetamine ............................ 1100 II 

Methamphetamine .................... 1105 II 

Lisdexamfetamine ..................... 1205 II 

Methylphenidate ........................ 1724 II 

ANPP (4-Anilino-N-phenethyl-4- 

piperidine).

8333 II 

Phenylacetone .......................... 8501 II 

Cocaine ..................................... 9041 II 

Codeine ..................................... 9050 II 

Dihydrocodeine ......................... 9120 II 

Oxycodone ................................ 9143 II 

Hydromorphone ........................ 9150 II 

Hydrocodone ............................. 9193 II 

Levorphanol .............................. 9220 II 

Meperidine ................................ 9230 II 

Meperidine intermediate–A ....... 9232 II 

Meperidine intermediate–B ....... 9233 II 

Meperidine intermediate–C ....... 9234 II 

Methadone ................................ 9250 II 

Methadone intermediate ........... 9254 II 

Morphine ................................... 9300 II 

Oripavine ................................... 9330 II 

Thebaine ................................... 9333 II 

Opium, powdered ..................... 9639 II 

Opium, granulated .................... 9640 II 

Oxymorphone ........................... 9652 II 

Noroxymorphone ...................... 9668 II 

Racemethorphan ...................... 9732 II 

Alfentanil ................................... 9737 II 

Remifentanil .............................. 9739 II 

Sufentanil .................................. 9740 II 

Tapentadol ................................ 9780 II 

Fentanyl .................................... 9801 II 

The company plans to manufacturer 

the listed controlled substances in bulk 

for distribution and sale to its 

customers. 

In reference to drug code 7360 

(Marihuana) and 7370 

(Tetrahydrocannabinols), the company 

plans to bulk manufacture these drugs 

as a synthetic. No other activities for 

this drug code are authorized for this 

registration. 

William T. McDermott, 

Assistant Administrator. 

[FR Doc. 2021–03836 Filed 2–24–21; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–791] 

Bulk Manufacturer of Controlled 

Substances Application: S&B Pharma, 

Inc. 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: S&B Pharma, Inc., has applied 

to be registered as a bulk manufacturer 

of basic class(es) of controlled 

substance(s). Refer to Supplemental 

Information listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before April 26, 2021. Such persons 

may also file a written request for a 

hearing on the application on or before 

April 26, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on November 11, 2020, 

S&B Pharma, Inc., 405 South Motor 

Avenue, Azusa, California 91702–3232, 

applied to be registered as an bulk 

manufacturer of the following basic 

class(es) of controlled substance(s): 

Controlled substance Drug 

code Schedule 

Gamma Hydroxybutyric Acid .... 7360 I 

Tetrahydrocannabinols ............. 7370 I 

Amphetamine ............................ 1100 II 

Methamphetamine .................... 1105 II 

Lisdexamfetamine ..................... 1205 II 

Methylphenidate ........................ 1724 II 

Pentobarbital ............................. 2270 II 

4-Anilino-N-phenethyl-4-piperidine (ANPP).8333 II 

Tapentadol ................................ 9780 II 

Fentanyl .................................... 9801 II 

The company plans to manufacture 

the listed controlled substances in bulk 

for use in product development and for 

commercial sales to its customers. In 

reference to drug code 7360 (Marihuana) 

and 7370 (Tetrahydrocannabinols), the 

company plans to bulk manufacture 

both as synthetic substances. No other 

activity for these drug codes is 

authorized for this registration. 

William T. McDermott, 

Assistant Administrator. 

[FR Doc. 2021–03837 Filed 2–24–21; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA798] 

Importer of Controlled Substances 

Application: Myonex Inc 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Myonex Inc has applied to be 

registered as an importer of basic 

class(es) of controlled substance(s). 

Refer to Supplemental Information 

listed below for further drug 

information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before March 29, 2021. Such persons 

may also file a written request for a 

hearing on the application on or before 

March 29, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing must 

be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All request for a hearing 

should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/OALJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DPW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on January 6, 2021, 

Myonex Inc, 48 East Main Street, 

Norristown, Pennsylvania 19401–4915, 

applied to be registered as an importer 

of the following basic class(es) of 

controlled substance(s): 

Controlled substance Drug 

code Schedule 

Amphetamine ................. 1100 II 

Lisdexamfetamine .......... 1205 II 

Methylphenidate ............. 1724 II